The progress on sulfhydryl modified polymers with regard to synthesis, characterization and mucoadhesion

The concepts of mucoadhesion and mucoadhesive polymers were introduced in the 20th century, leading to several advantages. These included enhanced drug absorption and extended residence at specific site of action. Polymeric excipients underwent chemical modification with sulfhydryl groups on the polymeric backbone so as to improve mucoadhesive features as well as potential. This modification resulted in compounds mimicking the nature of secreted mucus glycoproteins. Thus, these thiol group-bearing excipients presented the ability to attach covalently to the mucosa by the disulfide bonding. Nevertheless, the first generation of these thiol-modified polymers, named thiomers, presented disadvantages such as low stability in aqueous media and/or the high susceptibility towards oxidation along with the drawback of low sufficient reactive functional moieties on the polymeric backbone at lower pH.

Therefore, in the 21st century, a second generation of preactivated or S-protected polymers with protected thiol moieties were developed, as well as a third generation of thiomers, solving some of the previously described problems. This review article aimed to highlight the progess on a potent sulfhydryl modification during the last decades and the posterior characterization and in vitro/ex vivo/in vivo mucoadhesiveness. Continue on the progress on sulfhydryl modified polymers with regard to synthesis, characterization and mucoadhesion

Keywords: Chitosan, cysteine, drug delivery, hyaluronic acid, mucoadhesion, polymers

Cationic polymers

Chitosan, Dextran, Cellulose, Poly (allylamine), Poly (amidoamin, Poly (amino- co-ester)

Anionic polymers

Hyaluronic Acid, Carboxymethyl cellulose, Poly (acrylic acid), Poly (ethylene glycol)

Non-ionic polymers

Poly (ethylene oxide), Poly (vinyl alcohol), Poly (vinyl pyrrolidone), Polyacrylamide